Connect with us

Technology

Piezo Therapeutics Announces Formation of Scientific Advisory Board with Industry Veterans and Academic Luminaries

Published

on

World-renowned experts across infectious diseases, vaccines, and dermatology to advise Piezo on advancing its energy-based delivery platform and internal programs to the clinic

ATLANTA, April 21, 2025 /PRNewswire-PRWeb/ — Piezo Therapeutics, a biotechnology company pioneering energy-driven genetic medicines, announced today the formation of its Scientific Advisory Board (“SAB”) with leaders in infectious diseases, vaccines, and skin biology. The inaugural SAB will work closely with Piezo’s leadership team to provide technical insights and strategic guidance as Piezo advances its energy-based delivery platform (Piezopen) for its wholly owned programs and with pharma/biotech partners. Members of Piezo’s SAB bring decades of experience across RNA vaccines and therapeutics, DNA medicines, drug delivery, and dermatology.

“Our distinguished SAB will allow the company to continue its commitment to the highest-quality science focused on addressing unmet medical needs through energy-driven genetic medicines.” – Mark Prausnitz, PhD, Piezo co-founder and Regents’ Professor at Georgia Tech

“We are honored to welcome an illustrious group of industry veterans and academic leaders to our SAB as we advance Piezopen to the clinic,” said Gaurav Byagathvalli, CEO of Piezo. “Our SAB members have dedicated their careers to advancing novel medicines and deciphering human biology to prevent and cure life-threatening diseases. We look forward to drawing upon their deep expertise across multiple therapeutic areas as we advance our internal programs and ongoing collaborations towards first-in-human studies.”

Mark Prausnitz, PhD, Piezo co-founder and Regents’ Professor at Georgia Tech, added that “Piezo was founded on rigorous science and technology development at Georgia Tech. Our distinguished SAB will allow the company to continue its commitment to the highest-quality science focused on addressing unmet medical needs through energy-driven genetic medicines.”

The SAB includes (in alphabetical order):

Dr. Kate Broderick, PhD: Dr. Broderick has more than 20 years of experience in the life science industry. A recognized vaccine expert, Dr. Broderick has a broad background in device and product development in the DNA therapeutic and drug delivery field. Prior to joining Maravai in 2022 as the Chief Innovation Officer, Dr. Broderick held roles of increasing responsibility at Inovio Pharmaceuticals, most recently as Senior Vice President, R&D. Dr. Broderick has served as a principal investigator for a variety of grants and awards from government agencies and non-profits, including the National Institutes of Health. She received her PhD from the University of Glasgow in Scotland and completed her post-doctoral research at the University of California, San Diego.Dr. Elaine Fuchs, PhD: Dr. Fuchs is renowned for her research in skin biology, its stem cells and associated disorders, including cancers and inflammation. She is an Investigator of the Howard Hughes Medical Institute and has published >380 manuscripts. She received her PhD from Princeton in Biochemistry, her postdoctorate in Cell Biology at MIT, and has been on the faculty, first at University of Chicago and now Rockefeller University. Her awards include the National Medal of Science, L’Oreal-UNESCO Award, International Society for Stem Cell Research’s Innovation Award, the Gairdner International Award and the Franklin Medal. Dr. Fuchs holds membership in the National Academy of Sciences, National Academy of Medicine, American Philosophical Society, Pontifical Academy of Sciences, and the Royal Society. She is an inaugural member of the Academy of the American Association for Cancer Research, and now serves as its President.Dr. Norbert Pardi, PhD: Dr. Pardi holds a PhD in biochemistry and genetics from the University of Szeged, Hungary. He has been working at the University of Pennsylvania since 2011 and currently holds an Associate Professor position at the Department of Microbiology of the Perelman School of Medicine. He received training from Drs. Katalin Kariko and Drew Weissman at the University of Pennsylvania before he started his laboratory. His research interest is the development of mRNA-based therapeutics with particular focus on new-generation infectious disease vaccines. He explored the development of a novel vaccine platform using nucleoside-modified mRNA in lipid nanoparticles (LNPs) and used it to generate highly effective vaccines targeting various pathogens (influenza virus, coronaviruses, malaria and others). Dr. Pardi is a pioneer of the nucleoside-modified mRNA vaccine technology and published milestone papers in the field.Dr. Jeffrey Ulmer, PhD: Dr. Ulmer spent more than 30 years in vaccines R&D at Merck Research Laboratories, Chiron Corporation, Novartis and GlaxoSmithKline. His most recent leadership positions included Global Head, External R&D; Head, Preclinical R&D; and Program Head, Technical R&D. His scientific focus has been vaccine technology platforms, including DNA and mRNA vaccines, viral vectors and adjuvants. He received his Ph.D. in biochemistry from McGill University and a postdoctoral fellowship in the laboratory of Nobel laureate Dr. George Palade in the Department of Cell Biology at Yale University School of Medicine. He has published over 220 scientific articles, is an inventor on 11 patents, and is a Fellow of the International Society for Vaccines, where he serves as Vice-Chair of the Executive Board. He is currently President and CEO of TechImmune LLC, a biotechnology company based in Newport Beach, CA.

About Piezopen Platform

Our proprietary Piezopen platform enables localized yet highly efficient delivery of RNA and DNA without the need for lipid nanoparticles or viral vectors, with applications in infectious disease, cancer, chronic disease, and dermatology. In preclinical models, we have demonstrated robust induction of humoral and cellular responses to infectious disease and cancer vaccines with increased tolerability, dosing flexibility, and payload versatility. In human subjects, Piezopen was well accepted and shown to elicit superior tolerability compared to a hypodermic needle. Piezopen combines two innovations to surpass the limitations of formulations: piezoelectric pulses and microelectrodes for energy-based nucleic acid delivery. Piezopen improves the tolerability and efficacy of RNA/DNA medicines while slashing costs, simplifying manufacturing, and transforming scalability.

About Piezo Therapeutics

Piezo Therapeutics is a spinout from Georgia Tech focused on enabling next-gen nucleic acid vaccines and therapeutics via energy-based delivery. Integrating innovations in drug delivery and genetic medicine, Piezo is advancing its delivery platform and investigational therapeutics in collaboration with global pharma and biotech companies to prevent and treat debilitating diseases. The company raised its initial financing in 2023 backed by Good Ventures. For more information, please visit www.piezotx.com.

Media Contact

Gaurav Byagathvalli, Piezo Therapeutics, 1 4049973263, partnerships@piezotx.com, www.piezotx.com

View original content to download multimedia:https://www.prweb.com/releases/piezo-therapeutics-announces-formation-of-scientific-advisory-board-with-industry-veterans-and-academic-luminaries-302429880.html

SOURCE Piezo Therapeutics

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

DCCM Acquires Dynamic Solutions, LLC Expanding Water Resources Expertise

Published

on

By

DCCM has acquired Dynamic Solutions, LLC, a consulting firm recognized for advanced water resources, hydraulic, and hydrodynamic modeling. Dynamic Solutions expands DCCM’s technical capabilities in water and environmental modeling to better serve complex infrastructure and water-related client needs. Dynamic Solutions, founded in 1996 and offering services including watershed/hydrology studies, sediment transport, water quality, and ecological modeling, will continue operating with its existing leadership and team.

HOUSTON, May 4, 2026 /PRNewswire-PRWeb/ — DCCM, a national provider of design, consulting, and program and construction management professional services, is pleased to announce the acquisition of Dynamic Solutions, LLC, a specialized consulting firm known for advanced water resources, hydraulic, and hydrodynamic modeling.

“This acquisition expands DCCM’s technical capabilities in advanced water and environmental modeling while strengthening our ability to serve clients facing complex infrastructure and water-related challenges,” said James F. (Jim) Thompson, PE, Chairman and CEO of DCCM.

Founded in 1996, Dynamic Solutions is nationally recognized for its expertise in hydraulic and hydrodynamic modeling, watershed and hydrology studies, sediment transport, water quality, and ecological modeling. The firm supports clients across federal, state, and local markets, as well as select technical advisory engagements, delivering analytical solutions for complex water and environmental challenges.

Dynamic Solutions operates from offices in Knoxville, Tennessee; Baton Rouge, Louisiana; Columbus, Mississippi; and Hamilton, Ohio, supporting projects nationwide.

“This acquisition expands DCCM’s technical capabilities in advanced water and environmental modeling while strengthening our ability to serve clients facing complex infrastructure and water-related challenges,” said James F. (Jim) Thompson, PE, Chairman and CEO of DCCM. “Dynamic Solutions brings a depth of expertise and a reputation for technical excellence that aligns well with our long-term growth strategy.”

Dynamic Solutions will continue to operate with its existing leadership and team, maintaining its specialized service offerings and longstanding client relationships.

“Joining DCCM allows us to build on the outstanding work our team is known for while gaining access to broader resources and a national platform,” said Julie Wallen of Dynamic Solutions. “We look forward to continuing to deliver the same high level of service to our clients as part of the DCCM organization.”

About Dynamic Solutions, LLC

Dynamic Solutions, LLC is a consulting firm specializing in hydraulic and hydrodynamic modeling, watershed and hydrology studies, sediment transport, water quality, and ecological modeling. Founded in 1996, the firm serves public sector and institutional clients across the United States.

About DCCM

DCCM is a provider of design, consulting, and program and construction management professional services focused on infrastructure across the public and private sectors. Through a national platform, DCCM serves a diverse range of end markets.

DCCM is a portfolio company of Court Square Capital Partners.

For more information, please visit www.dccm.com.

Media Contact

Jessica Steglich, DCCM, 1 7138749162, marketing@dccm.com, dccm.com

View original content:https://www.prweb.com/releases/dccm-acquires-dynamic-solutions-llc-expanding-water-resources-expertise-302760882.html

SOURCE DCCM

Continue Reading

Technology

Modine to Participate in Upcoming Oppenheimer Virtual Conference on May 5, 2026

Published

on

By

RACINE, Wis., May 4, 2026 /PRNewswire/ — Modine (NYSE: MOD), a diversified global leader in thermal management technology and solutions, announced today that it will participate in the Oppenheimer 21st Annual Industrial Growth Conference on Tuesday, May 5, 2026.

Neil D. Brinker, Modine President and Chief Executive Officer, and Michael B. (Mick) Lucareli, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat during the conference on Tuesday, May 5, 2026, at 1:30 p.m. Eastern time (12:30 p.m. Central Time).

Live webcasts of the event will be available in the Investor Relations section of Modine’s website www.modine.com. Recordings of the events will be available for 365 days following the webcast.

About Modine
For more than 100 years, Modine has solved the toughest thermal management challenges for mission-critical applications. Our purpose of Engineering a Cleaner, Healthier World™ means we are always evolving our portfolio of technologies to provide the latest heating, cooling, and ventilation solutions. Through the hard work of more than 11,000 employees worldwide, our Climate Solutions, Data Centers, and Performance Technologies segments advance our purpose with systems that improve air quality, reduce energy and water consumption, lower harmful emissions, and enable the transition to a more sustainable future. Modine is a global company headquartered in Racine, Wisconsin (U.S.), with operations in North America, South America, Europe, and Asia. For more information about Modine, visit modine.com.

Investor Contact
Kathleen Powers
(262) 636-1687
kathleen.t.powers@modine.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/modine-to-participate-in-upcoming-oppenheimer-virtual-conference-on-may-5-2026-302760409.html

SOURCE Modine

Continue Reading

Technology

Blaize and Winmate Sign Strategic Partnership Agreement to Bring AI to Rugged Systems for Defense and Critical Infrastructure

Published

on

By

Joint solutions combine Blaize’s energy-efficient and industrial-grade AI chips with Winmate’s rugged platforms – including drones, handhelds, vehicle-mounted units, and embedded edge devices used by defense, border security, maritime, and healthcare operators.

TAIPEI and EL DORADO HILLS, Calif., May 4, 2026 /PRNewswire/ — Blaize Holdings, Inc. (Nasdaq: BZAI, Nasdaq: BZAIW) (“Blaize,” the “Company,” “we,” “our,” or “us”), and Winmate Inc., a publicly traded company in Taiwan, today announced they have signed a Strategic Partnership Agreement (“Agreement”) with an intent to close approximately $15 million in business during the first year. The two companies will integrate Blaize’s AI chips into Winmate’s rugged systems, including drones, handhelds, vehicle-mounted units, and embedded devices that have to keep working in the field, often in places where regular hardware can’t survive.

The companies expect the Agreement to be the start of a much larger, multi-year relationship.

Why this partnership matters

Most AI today runs in large data centers rather than at the edge, where decisions must be made in real time. This model is often impractical for soldiers at remote posts, Coast Guard crew at sea, or medics in field clinics. They often don’t have a reliable network connection, and even when they do, they can’t afford to wait for an application to respond from halfway across the globe.

That’s the gap Blaize and Winmate intend to address through this partnership. Blaize’s chips were designed to industrial grade specifications and run AI directly on the device, with no cloud dependency. Winmate’s systems are purpose-built to perform in extreme environments, including heat, cold, dust, vibration, and rough handling. Together, they deliver real-time AI capabilities exactly where it’s needed, whether in drones, field units, the patrol vehicles, or diagnostic devices.

A fast-growing market

Demand for on-device AI is accelerating. According to BCC Research[1], the global edge AI market is projected to grow from $11.8 billion in 2025 to $56.8 billion by 2030, a 36.9% compound annual growth rate. Defense agencies, governments, hospitals, ports, and critical infrastructure operators all demand AI that can run securely on their equipment, without sending sensitive data over public networks.

From the leaders

“Our customers can’t wait, and they often can’t rely on the cloud. They need AI that runs where the work happens. Winmate makes some of the most capable rugged systems in the industry, and our chips are designed to run AI inside exactly those kinds of devices. This partnership turns a years-long vision into a practical, deployable answer for defense and critical infrastructure operators,” said Dinakar Munagala, CEO of Blaize, Inc.

“Our platforms are deployed on naval vessels, in border outposts, on industrial sites, and in disaster zones – environments where most hardware fails. With Blaize, we can now deliver those same systems with on-device AI built in, giving customers real-time intelligence wherever they operate,” said Ken Lu, Chairman and CEO of Winmate Inc.

Target applications

Border security and surveillance: Real-time threat detection and perimeter monitoringMobile command and control: On-site intelligence and situational awareness for field teamsDrones and unmanned systems: Autonomous navigation and mission execution for UAVs and ground vehiclesCritical infrastructure: Continuous monitoring and predictive analytics for power, ports, and transportationMaritime domain awareness: Vessel tracking and anomaly detection at seaField healthcare: Portable diagnostics and decision support in remote and disaster environments

Deal at a glance

First-year revenue: the parties intend to work in good faith to close approximately $15 million in business, expected to scale meaningfully in subsequent yearsTerm: Three-year initial term, with automatic renewalNext steps: Joint engineering, sales, and marketing execution to bring integrated systems to market, with additional opportunities to be added through follow-on programs

[1] BCC Research, “Global Edge AI Market,” October 2025

About Blaize, Inc.

Blaize delivers a programmable AI platform, purpose-built for AI inference workloads in real-world environments. Its Hybrid AI architecture combines the Blaize GSP (Graph Streaming Processor) with GPU-based infrastructure, enabling AI inference workloads to run across edge, cloud, and data center. Blaize solutions support computer vision, multimodal AI, and sensor-driven applications across smart cities, industrial automation, telecommunications, retail, logistics, and defense. Blaize is headquartered in El Dorado Hills, California, with a global presence across North America, Europe, the Middle East, and Asia. Visit www.blaize.com or follow us on LinkedIn @blaizeinc.

About Winmate Inc.

Winmate Inc. is a publicly traded global leader in rugged computing systems, delivering industrial-grade platforms – including handhelds, tablets, vehicle-mounted units, panel PCs, and embedded modules – for demanding environments across defense, transportation, energy, healthcare, and industrial markets.

Cautionary Statement Regarding Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are based on beliefs and assumptions and on information currently available to Blaize, including expectations and scope of customer contracts, including the Strategic Partnership Agreement with Winmate, the potential value and the timing of revenue pursuant to such contracts, preliminary estimates of results of operations and guidance on results for future periods, the industry in which Blaize operates, market opportunities, and product offerings. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” “target,” “seek” or the negative or plural of these words, or other similar expressions that are predictions or indicate future events or prospects, although not all forward-looking statements contain these words. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this document, including but not limited to those factors discussed under the heading “Risk Factors” in our Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 24, 2026, and other documents filed by Blaize from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Blaize assumes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law, including the securities laws of the United States and the rules and regulations of the SEC. Blaize does not give any assurance that it will achieve its expectations.

Blaize Contact

press@blaize.com
www.blaize.com 

Investors

ir@blaize.com
www.blaize.com 

Winmate Inc.

Liu, Chih-Yuan
Tel: +886-2-8511-0288
Email: spokesman1@winmate.com.tw
https://www.winmate.com/ 

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/blaize-and-winmate-sign-strategic-partnership-agreement-to-bring-ai-to-rugged-systems-for-defense-and-critical-infrastructure-302761250.html

SOURCE Blaize Inc.

Continue Reading

Trending